Patient Alert: Our scheduling system is back online. The appointment reminder system is still down, appointment reminders are not currently being sent.

Trial Protocol ID
USOR 23062_56021927PCR3020_LIBERTAS

Investigator
Vinni Juneja, M.D.

A Phase 3, Open-label, Randomized, Prospective Study of Apalutamide with Continued Versus Intermittent Androgen-Deprivation Therapy (ADT) following PSA Response in Participants with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Trial Protocol ID
USOR 20138_D361BC00001 *STAR*

A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Abiraterone Versus Placebo + Abiraterone as Treatment for Patients with De Novo Metastatic Hormone Sensitive Prostate Cancer(mHSPC) Characterised by PTEN deficiency (CAPItello-281)